[1] |
Xue Yong, Wu Xueqiong.
Interpretation of immune function status assessment in Expert consensus on immune function assessment and immunotherapy in patients with active tuberculosis (2021 edition)
[J]. Chinese Journal of Antituberculosis, 2023, 45(2): 134-138.
|
[2] |
Du Yanni, Xue Ming, Guan Chunshuang, Xing Yuxue, Chen Budong, Xie Ruming.
Analysis of atypical chest CT findings in AIDS patients complicated with pulmonary tuberculosis
[J]. Chinese Journal of Antituberculosis, 2023, 45(2): 159-164.
|
[3] |
Dai Zhenwei, Zhang Haoran, Jing Shu, Xiao Weijun, Wang Hao, Huang Yiman, Chen Xu, Fu Jiaqi, Wu Yijin, Gao Lei, Su Xiaoyou.
Effect of mindfulness level on mental health of middle-aged and elderly people with type 2 diabetes mellitus comorbidity latent tuberculosis infection in rural areas
[J]. Chinese Journal of Antituberculosis, 2023, 45(2): 188-194.
|
[4] |
Zhou Yan, Zhou Meng, Peng Jun, Duan Qionghong, Chen Jun, Zhou Meilan, Zhang Yunxia, Liang Jun.
Analysis on transmission of multidrug-resistant pulmonary tuberculosis in family
[J]. Chinese Journal of Antituberculosis, 2023, 45(2): 195-199.
|
[5] |
Qu Yunmo, Ding Xinyuan, Yan Meiyi, Guo Xiaopeng, Sun Yicheng.
Development and application of CRISPR assisted genome editing technology in Mycobacterium tuberculosis
[J]. Chinese Journal of Antituberculosis, 2023, 45(2): 208-214.
|
[6] |
Wang Zeming, Shen Adong.
Interpretation of the standard of Detection and preventive treatment of latent tuberculosis infection in children
[J]. Chinese Journal of Antituberculosis, 2023, 45(1): 13-17.
|
[7] |
Fan Lichao, Jiao Weiwei, Wu Haoyu, Shen Adong, Chen Yu.
Interpretation of WHO consolidated guidelines on tuberculosis. Module 5: management of tuberculosis in children and adolescents
[J]. Chinese Journal of Antituberculosis, 2023, 45(1): 6-12.
|
[8] |
Yu Meiling, Zhang Chenchen, Wei Wenjing, Zhao Yuchuan, Zhuo Wenji, Zheng Lei.
Study on high-concentration p-aminosalicylic acid resistant Mycobacterium tuberculosis induced in vitro and the mutation sites
[J]. Chinese Journal of Antituberculosis, 2023, 45(1): 60-66.
|
[9] |
Sheng Yunfeng, Qiu Meihua, Chen Yuanyuan, Sun Lifang, Zhen Libo.
Research on mechanisms of dendritic cell miR-17 regulating naive CD4+T lymphocytes unevenly differentiating to Treg/Th17
[J]. Chinese Journal of Antituberculosis, 2023, 45(1): 67-72.
|
[10] |
Wei Shuzhen, Zhao Yong, Lin Jian, Lin Shufang, Dai Zhisong.
Analysis of genotype characteristics and drug resistance of Mycobacterium tuberculosis isolates in Fujian Province from 2017 to 2019
[J]. Chinese Journal of Antituberculosis, 2023, 45(1): 73-78.
|
[11] |
National Clinical Research Centre for Infectious Disease/The Third People’s Hospital of Shenzhen, Peking University Shenzhen Hospital, Peking Union Medical College Hospital of Chinese Academy of Medical Sciences, Chinese Antituberculosis Association, Editorial Board of Chinese Journal of Antituberculosis, Shenzhen Key Laboratory of Inflammatory and Immune Diseases.
Expert consensus on diagnosis and treatment of latent tuberculosis infection in patients with rheumatic diseases
[J]. Chinese Journal of Antituberculosis, 2022, 44(9): 869-879.
|
[12] |
Wang Yuxiang, Chen Qiuqi, Yu Xinxin, Zhan Senlin, Zhang Peize, Deng Guofang.
3HP regimen in the treatment of rheumatic diseases complicated with Mycobacterium tuberculosis latent infection:a prospective study
[J]. Chinese Journal of Antituberculosis, 2022, 44(9): 906-910.
|
[13] |
Xie Jingyi, Zou Ruifeng, Chen Yulan, Chen Yong, Liu Dongzhou, Hong Xiaoping.
Analysis of clinical features and peripheral lymphocyte subsets of systemic lupus erythematosus patients complicated with tuberculosis infection
[J]. Chinese Journal of Antituberculosis, 2022, 44(9): 911-916.
|
[14] |
Cheng Xiao, Chen Zhe, Jiao Xuefeng, Yang Nan, Diao Sha, Ni Xiaofeng, Liu Zheng, He Siyi, Zeng Linan, Wan Chaomin, Kang Deying, Wu Bin, Ying Binwu, Zhang Hui, Zhao Rongsheng, Zhang Lingli.
Efficacy and safety of recombinant Mycobacterium tuberculosis fusion proteins (EC) for the diagnosis of Mycobacterium tuberculosis infection: A system review
[J]. Chinese Journal of Antituberculosis, 2022, 44(9): 917-926.
|
[15] |
Wu Wenqi, Zhong Jianqiu, He Juan, Deng Guofang, Wang Qingwen.
The research progress of the reactivation of latent tuberculosis infection in patients with rheumatic diseases
[J]. Chinese Journal of Antituberculosis, 2022, 44(9): 954-959.
|